Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer-Reference-Cited by-同舟云学术

Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer

Published:2021-10-01 Issue:10 Volume:147 Page:871
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Masarwy Razan¹,Kampel Liyona¹,Horowitz Gilad¹,Gutfeld Orit²,Muhanna Nidal¹

Affiliation:

1. Department of Otolaryngology–Head and Neck and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

2. Institute of Radiation Therapy, Division of Oncology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2783964/jamaotolaryngology_masarwy_2021_oi_210041_1633715075.32116.pdf

Reference50 articles.

1. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck.;Shin;Head Neck,2013

2. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.;Haddad;Lancet Oncol,2013

3. Nivolumab for recurrent squamous-cell carcinoma of the head and neck.;Ferris;N Engl J Med,2016

4. Pembrolizumab after progression on platinum and cetuximab in head and neck squamous cell carcinoma (HNSCC): results from KEYNOTE-055.;Haddad;Ann Oncol,2016

5. Induction chemotherapy for squamous cell carcinomas of the oral cavity: a cumulative meta-analysis.;Lau;Oral Oncol,2016

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of acupuncture in head and neck cancer;Head and Neck Cancer Rehabilitation;2025

2. Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer – detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients’ peripheral blood;Frontiers in Oncology;2024-09-13

3. The impact of elective cervical lymph node treatment on the tumour immune response in head and neck squamous cell carcinoma: time for a change in treatment strategy?;BJC Reports;2024-09-09

4. Secretome and immune cell attraction analysis of head and neck cancers;Cancer Immunology, Immunotherapy;2024-09-09

5. Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma;Oral Oncology;2024-09